Back to the list
Congress: ECR25
Poster Number: C-10265
Type: Poster: EPOS Radiologist (scientific)
Authorblock: F. Herr, M. J. Antons, L. Blume, J. Stueckl, H. Hirner-Eppeneder, J. Ricke, M. Heimer, D-A. Clevert, C. C. Cyran; München/DE
Disclosures:
Felix Herr: Nothing to disclose
Melissa J. Antons: Nothing to disclose
Larissa Blume: Nothing to disclose
Jennifer Stueckl: Nothing to disclose
Heidrun Hirner-Eppeneder: Nothing to disclose
Jens Ricke: Nothing to disclose
Maurice Heimer: Nothing to disclose
Dirk-André Clevert: Nothing to disclose
Clemens C. Cyran: Nothing to disclose
Keywords: Molecular imaging, Oncology, Ultrasound physics, MR-Functional imaging, PET-CT, Ultrasound, Experimental investigations, Molecular imaging, Radionuclide therapy, Cancer, Image guided radiotherapy, Molecular, genomics and proteomics
References

1. Baetke SC, Rix A, Tranquart F, Schneider R, Lammers T, Kiessling F, et al. Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects. Radiology. 2016;278:430–40.

2. Baron Toaldo M, Salvatore V, Marinelli S, Palamà C, Milazzo M, Croci L, et al. Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma. Mol Imaging Biol. 2015;17:29–37.

3. Eschbach RS, Clevert D-A, Hirner-Eppeneder H, Ingrisch M, Moser M, Schuster J, et al. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation. PloS One. 2017;12:e0169323. 
GALLERY